Last updated on: 9/24/2019 | Author:

Nov. 10, 2009 – AMA Softens Position on Scheduling of Marijuana

The American Medical Association softens its position on medical marijuana in a policy statement released Nov. 10, 2009. The statement read in part: “Our AMA urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product.”

Prior to the Nov. 10, 2009 position quoted above, the AMA had recommended that marijuana be retained in Schedule I of the Controlled Substances Act pending the outcome of further studies.